Frederick Pierce
Chief Executive Officer at INNOVATION1 BIOTECH INC.
Profile
Frederick E.
Pierce is the founder of FEP Capital Advisors LLC, Decoy Therapeutics, Inc., and Innovation1 Biotech, Inc. Currently, he serves as the Chairman, President & Chief Executive Officer at Innovation1 Biotech, Inc. He is also a Director at Canadian Entrepreneurs In New England and holds the position of Vice President-Investor & Media Relations at MetaStat, Inc. In the past, Mr. Pierce has held positions such as Interim Chief Executive Officer at Glycogenesys, Inc. from 1998 to 2006, Chairman & Chief Executive Officer at SanaRx Biotherapeutics, Inc., Chief Executive Officer at Microbial Machines, Inc., Chairman at Leadership Counsel for Justice & Accountability from 2017 to 2020, President-US & International Operations at SemBioSys Genetics, Inc., and Vice President-Investor Relations at Javelin Pharmaceuticals, Inc. He completed his undergraduate degree at Hampshire College.
Frederick Pierce active positions
| Companies | Position | Start |
|---|---|---|
| METASTAT, INC. | Investor Relations Contact | 2015-02-28 |
| INNOVATION1 BIOTECH INC. | Chief Executive Officer | 2022-12-05 |
| Decoy Therapeutics, Inc. | Chief Executive Officer | - |
Canadian Entrepreneurs In New England
 Canadian Entrepreneurs In New England Miscellaneous Commercial ServicesCommercial Services Canadian Entrepreneurs In New England operates a membership organization that supports Canadian technology and life sciences entrepreneurs. The private company is based in Boston. The American company was founded by Chris Legg. | Director/Board Member | - |
Former positions of Frederick Pierce
| Companies | Position | End |
|---|---|---|
Leadership Counsel for Justice & Accountability
 Leadership Counsel for Justice & Accountability Miscellaneous Commercial ServicesCommercial Services Leadership Counsel for Justice & Accountability is an organization that aims to address the inequality faced by low-income rural regions in the United States. The organization fundamentally shifts the dynamics that have created this inequality, with a focus on the Sa region. | Chairman | 2019-12-31 |
Glycogenesys, Inc.
 Glycogenesys, Inc. Miscellaneous Commercial ServicesCommercial Services GlycoGenesys, Inc., a biotechnology company, develops novel pharmaceutical products based on carbohydrate compounds and related technologies. The company's lead drug candidate GCS-100, a treatment for various forms of solid tumors and bloodborne cancers, completed a Phase II (a) clinical trial for pancreatic cancer, and also completed a Phase II (a) clinical trial for colorectal cancer. The company focuses on the development of carbohydrate-based pharmaceutical products and related technologies in connection with oncology. It was founded in 1992 and is headquartered in Boston, MA. | President | 2006-05-31 |
| Microbial Machines, Inc. | Chief Executive Officer | - |
| SEMBIOSYS GENETICS I | Corporate Officer/Principal | - |
SanaRx Biotherapeutics, Inc.
 SanaRx Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology SanaRx Biotherapeutics, Inc. is a biotechnology company. It serves patients with orphan diseases of the alimentary tract. The company is headquartered in Medford, MA. | Chief Executive Officer | - |
Training of Frederick Pierce
| Hampshire College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| METASTAT, INC. | Producer Manufacturing |
| INNOVATION1 BIOTECH INC. | Retail Trade |
| Private companies | 9 |
|---|---|
Glycogenesys, Inc.
Glycogenesys, Inc. Miscellaneous Commercial ServicesCommercial Services GlycoGenesys, Inc., a biotechnology company, develops novel pharmaceutical products based on carbohydrate compounds and related technologies. The company's lead drug candidate GCS-100, a treatment for various forms of solid tumors and bloodborne cancers, completed a Phase II (a) clinical trial for pancreatic cancer, and also completed a Phase II (a) clinical trial for colorectal cancer. The company focuses on the development of carbohydrate-based pharmaceutical products and related technologies in connection with oncology. It was founded in 1992 and is headquartered in Boston, MA. | Commercial Services |
SemBioSys Genetics, Inc.
 SemBioSys Genetics, Inc. BiotechnologyHealth Technology SemBioSys Genetics, Inc. operates as a plant-based technology development company, which engages in the manufacturing technology platforms to develop, manufacture and commercialize healthy living, animal health and pharmaceutical products. It offers proteins, functional food and nutritional products. The company was founded by Maurice Moloney on April 25, 1994 and is headquartered in Calgary, Canada. | Health Technology |
Javelin Pharmaceuticals, Inc.
 Javelin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Javelin Pharmaceuticals, Inc. develops pharmaceutical drugs. It is a specialty pharmaceutical company that applies innovative proprietary technologies to develop new drugs and improved formulations of existing drugs that target current unmet and underserved medical market. The company's product candidates address the acute moderate-to-severe pain medication market segment. It has three late stage product candidates in development: Dyloject (diclofenac sodium, injectable), Rylomine (intranasal morphine) and PMI-150 (intranasal ketamine). The company was founded on February 23, 1998 and is headquartered in Cambridge, MA. | Health Technology |
| FEP Capital Advisors LLC | |
Canadian Entrepreneurs In New England
Canadian Entrepreneurs In New England Miscellaneous Commercial ServicesCommercial Services Canadian Entrepreneurs In New England operates a membership organization that supports Canadian technology and life sciences entrepreneurs. The private company is based in Boston. The American company was founded by Chris Legg. | Commercial Services |
SanaRx Biotherapeutics, Inc.
SanaRx Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology SanaRx Biotherapeutics, Inc. is a biotechnology company. It serves patients with orphan diseases of the alimentary tract. The company is headquartered in Medford, MA. | Health Technology |
Leadership Counsel for Justice & Accountability
Leadership Counsel for Justice & Accountability Miscellaneous Commercial ServicesCommercial Services Leadership Counsel for Justice & Accountability is an organization that aims to address the inequality faced by low-income rural regions in the United States. The organization fundamentally shifts the dynamics that have created this inequality, with a focus on the Sa region. | Commercial Services |
| Decoy Therapeutics, Inc. | |
| Microbial Machines, Inc. |
- Stock Market
- Insiders
- Frederick Pierce
